| Primary |
| Depression |
13.2% |
| Affective Disorder |
9.4% |
| Aggression |
8.5% |
| Parkinson's Disease |
8.5% |
| Anxiety Disorder |
5.7% |
| Drug Use For Unknown Indication |
5.7% |
| Psychotic Disorder |
5.7% |
| Hallucination |
4.7% |
| Hypertension |
4.7% |
| Schizophrenia, Undifferentiated Type |
4.7% |
| Bipolar Disorder |
3.8% |
| Cholecystitis Acute |
3.8% |
| Anxiety |
2.8% |
| Epilepsy |
2.8% |
| Insomnia |
2.8% |
| Major Depression |
2.8% |
| Mental Disorder |
2.8% |
| Pain |
2.8% |
| Urinary Incontinence |
2.8% |
| Disturbance In Attention |
1.9% |
|
| Sedation |
10.3% |
| Somnolence |
10.3% |
| Multiple Drug Overdose |
6.9% |
| Platelet Disorder |
6.9% |
| Restlessness |
6.9% |
| Sleep Disorder |
6.9% |
| Urinary Incontinence |
6.9% |
| Abdominal Pain |
3.4% |
| Abortion Spontaneous |
3.4% |
| Depression |
3.4% |
| Drug Exposure During Pregnancy |
3.4% |
| Drug Withdrawal Syndrome |
3.4% |
| Gait Disturbance |
3.4% |
| Gastrointestinal Malformation |
3.4% |
| Hallucination, Visual |
3.4% |
| Hypertriglyceridaemia |
3.4% |
| Hyponatraemia |
3.4% |
| Ileus Paralytic |
3.4% |
| Inappropriate Antidiuretic Hormone Secretion |
3.4% |
| Inappropriate Schedule Of Drug Administration |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
53.9% |
| Drug Use For Unknown Indication |
16.0% |
| Schizoaffective Disorder |
6.9% |
| Depression |
3.7% |
| Anxiety |
3.1% |
| Hypertension |
2.5% |
| Schizophrenia, Undifferentiated Type |
2.3% |
| Schizophrenia, Paranoid Type |
1.8% |
| Essential Hypertension |
1.4% |
| Insomnia |
1.1% |
| Pain |
0.9% |
| Atrial Fibrillation |
0.9% |
| Bipolar I Disorder |
0.8% |
| Epilepsy |
0.8% |
| Drug Exposure During Pregnancy |
0.8% |
| Suicide Attempt |
0.8% |
| Schizophrenia |
0.7% |
| Hypothyroidism |
0.6% |
| Major Depression |
0.6% |
| Cardiac Failure |
0.5% |
|
| Vertigo |
14.2% |
| Urinary Retention |
10.1% |
| Vomiting |
8.3% |
| Hypophysitis |
6.0% |
| Suicide Attempt |
6.0% |
| Syncope |
6.0% |
| Somnolence |
5.5% |
| Tachycardia |
5.0% |
| Fall |
4.6% |
| Orthostatic Hypotension |
4.6% |
| Face Oedema |
4.1% |
| Sleep Disorder |
4.1% |
| Rhabdomyolysis |
3.2% |
| Schizophrenia |
3.2% |
| Sedation |
3.2% |
| Foetal Growth Retardation |
2.8% |
| Psychotic Disorder |
2.3% |
| Thrombocytopenia |
2.3% |
| Toxicity To Various Agents |
2.3% |
| Ventricular Septal Defect |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.9% |
| Drug Use For Unknown Indication |
20.6% |
| Depression |
7.2% |
| Hypertension |
5.3% |
| Anxiety |
3.7% |
| Prophylaxis |
3.5% |
| Schizophrenia |
2.7% |
| Pain |
2.6% |
| Insomnia |
2.2% |
| Crohn's Disease |
1.8% |
| Osteoporosis |
1.7% |
| Bipolar Disorder |
1.6% |
| Essential Hypertension |
1.6% |
| Psychotic Disorder |
1.5% |
| Rheumatoid Arthritis |
1.5% |
| Parkinson's Disease |
1.4% |
| Atrial Fibrillation |
1.4% |
| Nausea |
1.4% |
| Restlessness |
1.3% |
| Epilepsy |
1.1% |
|
| Weight Increased |
14.6% |
| Pulmonary Embolism |
10.0% |
| Vomiting |
7.3% |
| Thrombocytopenia |
6.9% |
| Overdose |
6.7% |
| Weight Decreased |
6.4% |
| Renal Failure Acute |
5.0% |
| Rhabdomyolysis |
5.0% |
| Tremor |
5.0% |
| Urinary Retention |
4.0% |
| Pyrexia |
3.5% |
| Somnolence |
3.5% |
| Hyponatraemia |
3.3% |
| Renal Failure |
3.1% |
| Sinus Tachycardia |
3.1% |
| Restless Legs Syndrome |
2.7% |
| Death |
2.5% |
| Suicidal Ideation |
2.5% |
| Syncope |
2.5% |
| Toxic Epidermal Necrolysis |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
37.0% |
| Schizophrenia |
13.0% |
| Anxiety Disorder |
11.6% |
| Product Used For Unknown Indication |
8.7% |
| Mental Disorder |
4.3% |
| Bipolar I Disorder |
3.6% |
| Personality Disorder |
3.6% |
| Agitation |
2.9% |
| Partial Seizures |
2.9% |
| Pain |
2.2% |
| Bronchopulmonary Aspergillosis |
1.4% |
| Depression |
1.4% |
| Drug Dependence |
1.4% |
| Major Depression |
1.4% |
| Sedation |
1.4% |
| Anxiety |
0.7% |
| Breast Cancer |
0.7% |
| Essential Hypertension |
0.7% |
| Sleep Disorder |
0.7% |
|
| Drug Interaction |
37.8% |
| Somnolence |
15.6% |
| Suicidal Ideation |
8.9% |
| Urinary Retention |
6.7% |
| Fall |
4.4% |
| Hyponatraemia |
2.2% |
| Ischaemic Stroke |
2.2% |
| Metastases To Central Nervous System |
2.2% |
| Off Label Use |
2.2% |
| Oxygen Saturation Decreased |
2.2% |
| Polydipsia |
2.2% |
| Pulmonary Embolism |
2.2% |
| Restlessness |
2.2% |
| Sopor |
2.2% |
| Supraventricular Tachycardia |
2.2% |
| Thrombophlebitis Septic |
2.2% |
| Toxicity To Various Agents |
2.2% |
|
